Elevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer
Authors:
Open Access
- 1 November 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (11) , 2829-2834
Abstract
Most inherited cancer syndromes are characterized by the familial clustering of cancers at several organ sites. To determine if cancers, other than pancreatic cancer, cluster in pancreatic cancer kindreds, we examined mortality patterns among the relatives of National Familial Pancreatic Tumor Registry probands. Over 200,000 person-years of follow-up from 8,564 first-degree relatives of probands and 1,007 spouse controls were included in these analyses. We compared mortality rates of National Familial Pancreatic Tumor Registry participants to US population rates using weighed standardized mortality ratios (wSMR). Analyses were stratified by family history of pancreatic cancer (sporadic versus familial), family history of young onset pancreatic cancer (<50 years), and family history score. Cancer mortality was increased in both the relatives of sporadic probands [wSMR 1.55, 95% confidence interval (95% CI) 1.39-1.73] and familial probands (wSMR 1.41, 95% CI 1.26-1.58). Relatives of familial probands had a significantly increased risk of dying from breast (wSMR 1.66, 95% CI 1.15-2.34), ovarian (wSMR 2.05, 95% CI 1.10-3.49), and bile duct cancers (wSMR 2.89, 95% CI 1.04-6.39). Relatives of sporadic probands were at increased risk of dying from bile duct cancer (wSMR 3.01, 95% CI 1.09-6.67). Relatives of young onset probands were at higher risk of dying from cancers of the breast (wSMR 1.98, 95% CI 1.01-3.52), colon (wSMR 2.31, 95% CI 1.30-3.81) and prostate (wSMR 2.31, 95% CI 1.14-4.20). Increased cancer mortality was not observed in the spouse controls. Our results show that relatives of pancreatic cancer patients are at higher risk of developing cancers at other sites and highlight the importance of complete family history in clinical risk assessment. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2829–34)Keywords
This publication has 31 references indexed in Scilit:
- The Prevalence of BRCA2 Mutations in Familial Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Risk factors for pancreatic cancerJournal of Cellular Biochemistry, 2005
- Cancer Disparities by Race/Ethnicity and Socioeconomic StatusCA: A Cancer Journal for Clinicians, 2004
- BRCA2 Germline Mutations in Familial Pancreatic CarcinomaJNCI: Journal of the National Cancer Institute, 2003
- Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.2002
- Germline and Somatic Mutations of the STK11/LKB1 Peutz-Jeghers Gene in Pancreatic and Biliary CancersThe American Journal of Pathology, 1999
- Socioeconomic Factors, Health Behaviors, and MortalityJAMA, 1998
- Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.1996
- A gene for hereditary pancreatitis maps to chromosome 7q35Gastroenterology, 1996